Trends of Nontraumatic Lower-Extremity Amputation in End-Stage Renal Disease and Diabetes: United States, 2000-2015

被引:38
作者
Harding, Jessica L. [1 ]
Pavkov, Meda E. [1 ]
Gregg, Edward W. [1 ]
Burrows, Nilka R. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA
关键词
FOOT ULCERATION; LIMB AMPUTATION; RISK; DIALYSIS;
D O I
10.2337/dc19-0296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Nontraumatic lower-extremity amputation (NLEA) is a complication of end-stage renal disease (ESRD) and diabetes. Although recent data show that NLEA rates in the U.S. ESRD population are declining overall, trends in diabetes and diabetes subgroups remain unclear. RESEARCH DESIGN AND METHODS We estimated annual rates of NLEA hospitalizations during 2000-2015 among >2 million adults (>= 18 years) with ESRD from the U.S. Renal Data System. Age, sex, and race-adjusted NLEA rates were stratified by diabetes status, age, sex, race, and level of amputation (toe, foot, below the knee, and above the knee). Time trends were assessed using Joinpoint regression with annual percent changes (APC) reported. RESULTS Among adults with diabetes, NLEA rates declined 43.8% between 2000 and 2013 (from 7.5 to 4.2 per 100 person-years; APC -4.9, P < 0.001) and then stabilized. Among adults without diabetes, rates of total NLEAs declined 25.5% between 2000 and 2013 (from 1.6 to 1.1; APC -3.0, P < 0.001) and then stabilized. These trends appear to be driven by a slowing or stagnation in declines of minor NLEAs (toe and foot) in more recent years, while major NLEAs (above the knee) continue to decline. CONCLUSIONS Despite an initial period of decline, this analysis documents a stall in progress in NLEA trends in recent years in a high-risk population with both ESRD and diabetes. Increased attention to preventive foot care in the ESRD population should be considered, particularly for those with diabetes.
引用
收藏
页码:1430 / 1435
页数:6
相关论文
共 50 条
  • [41] Comparison of the Functional Outcomes of Lower Limb Amputees with or without End-Stage Renal Disease
    Tsur, Atzmon
    Shakeer, Nael
    Geron, Ronit
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2019, 21 (09): : 585 - 588
  • [42] Clinical characteristics and outcomes of patients with end-stage renal disease hospitalized with diabetes ketoacidosis
    Galindo, Rodolfo J.
    Pasquel, Francisco J.
    Fayfman, Maya
    Tsegka, Katerina
    Dhruv, Neil
    Cardona, Saumeth
    Wang, Heqiong
    Vellanki, Priyathama
    Umpierrez, Guillermo E.
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
  • [43] Scleroderma at end stage renal disease in the United States: Patient characteristics and survival
    Abbott, KC
    Trespalacios, FC
    Welch, PG
    Agodoa, LYC
    JOURNAL OF NEPHROLOGY, 2002, 15 (03) : 236 - 240
  • [44] End-stage renal disease and survival in people with diabetes: a national database linkage study
    Bell, S.
    Fletcher, E. H.
    Brady, I.
    Looker, H. C.
    Levin, D.
    Joss, N.
    Traynor, J. P.
    Metcalfe, W.
    Conway, B.
    Livingstone, S.
    Leese, G.
    Philip, S.
    Wild, S.
    Halbesma, N.
    Sattar, N.
    Lindsay, R. S.
    Mcknight, J.
    Pearson, D.
    Colhoun, H. M.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2015, 108 (02) : 127 - 134
  • [45] END-STAGE RENAL DISEASE DUE TO DIABETES IN RACIAL/ETHNIC MINORITIES AND DISADVANTAGED POPULATIONS
    Lopes, Antonio Alberto
    ETHNICITY & DISEASE, 2009, 19 (01) : 47 - 51
  • [46] Comparison of trends in colorectal cancer screening in the US end-stage renal disease population and the US Medicare population
    Fwu, Chyng-Wen
    Kimmel, Paul L.
    Eggers, Paul W.
    Abbott, Kevin C.
    CLINICAL KIDNEY JOURNAL, 2016, 9 (05): : 722 - 728
  • [47] Joint modelling for organ transplantation outcomes for patients with diabetes and the end-stage renal disease
    Dong, Jianghu
    Wang, Shijia
    Wang, Liangliang
    Gill, Jagbir
    Cao, Jiguo
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2019, 28 (09) : 2724 - 2737
  • [48] Circulating proteins protect against renal decline and progression to end-stage renal disease in patients with diabetes
    Dom, Zaipul I. Md
    Satake, Eiichiro
    Skupien, Jan
    Krolewski, Bozena
    O'Neil, Kristina
    Willency, Jill A.
    Dillon, Simon T.
    Wilson, Jonathan M.
    Kobayashi, Hiroki
    Ihara, Katsuhito
    Libermann, Towia A.
    Pragnell, Marlon
    Duffin, Kevin L.
    Krolewski, Andrzej S.
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (600)
  • [49] Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival
    Abbott, KC
    Agodoa, LY
    CLINICAL NEPHROLOGY, 2001, 56 (03) : 207 - 210
  • [50] Changes in Excess Mortality from End Stage Renal Disease in the United States from 1995 to 2013
    Foster, Bethany J.
    Mitsnefes, Mark M.
    Dahhou, Mourad
    Zhang, Xun
    Laskin, Benjamin L.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (01): : 91 - 99